Eli Lilly and Company (NYSE: LLY) and Egypt-headquartered EVA Pharma have developed a plan to collaborate to supply at least one million people in low- and middle-income countries. Many of the recipients of the vaccines will be in Africa. Roughly a month ago, Lilly’s share price fell about 4% after a fake Twitter account stated…
FDA yanks EUA for Lilly’s bebtelovimab COVID-19 antibody
The FDA has pulled the emergency use authorization (EUA) for bebtelovimab, the monoclonal antibody from Eli Lilly (NYSE:LLY), because it no longer adequately protects against the BQ.1 and BQ.1.1 omicron subvariants. In late November, the BQ.1 variant was responsible for 27.9% of U.S. COVID-19 infections, according to CDC. The BQ.1.1 variant represented 29.4% of infections. Meanwhile,…
Lilly stock dips after fake Twitter profile makes bogus insulin announcement
Eli Lilly‘s (NYSE:LLY) share price dropped about 4% Friday to $352.36 after a fake Twitter account claimed the company would make insulin available at no cost. “We are excited to announce insulin is free now,” read the fake announcement from @EliLillyandCo, which received more than 1,500 retweets and 10,000 likes before Twitter removed the bogus…
Lilly establishing pharmaceutical manufacturing scholarship program at Purdue
Eli Lilly (NYSE:LLY) announced yesterday that it committed $92.5 million to establish a scholarship program at Purdue University. The funding establishes an innovative new pharmaceutical manufacturing scholarship program. Lilly and Purdue also renewed their strategic research collaboration. This involves a series of moves aimed at expanding their impact in Indiana and improving lives around the…
Lilly says proposed $2.1B facility investment could create up to 500 jobs
Eli Lilly and Co. (NYSE: LLY) plans to build two new factories in Indiana. The plants will bolster its supply of active ingredients and new therapeutic modalities. Both will be based in the LEAP Lebanon Innovation and Research District in Boone County, Indiana. The proposal could ultimately create as many as 500 new jobs. The…
Lilly to invest $1B in new plant in North Carolina
Eli Lilly and Co. (NYSE:LLY) said it would invest more than $1 billion to build a new manufacturing facility in Concord, North Carolina. The company says it would hire almost 600 new employees to staff the new site, which will include a campus of five buildings focused on manufacturing parenteral (injectable) products and devices. The…
Lilly beats Street in Q3, raises guidance on COVID-19 antibody revenues
Eli Lilly (NYSE:LLY) shares slightly dipped today on third-quarter results that topped the consensus forecast. The Indianapolis-based company posted profits of $1.1 billion, or $1.22 per share, on sales of $6.8 billion for the three months ended Sept. 30, 2021, for a -8.1% bottom-line slide on sales growth of 18%. Adjusted to exclude one-time items,…
Lilly prices first sustainability bond
Eli Lilly and Company (NYSE: LLY) has announced its plan to issue €600 million in aggregate principal in the amount of 0.50% notes with 12-year maturity as part of its Environmental, Social and Governance (ESG) strategy. In May, the company announced that it had updated its Environmental, Social and Governance (ESG) strategy, bolstering its investment…
Nominations open for the Leonard Award celebrating 100 years of insulin
Eli Lilly (NYSE:LLY) is looking for nominations for its inaugural Leonard Award series, which highlights advances in diabetes management. The company will select five winners and donate $100,00 to the non-profit Life for a Child, which provides medicines and supplies to children and youth with type 1 diabetes in developing countries. Lilly is launching the award program…
DoJ subpoenas Eli Lilly over bamlanivimab plant
In an SEC filing, Eli Lilly (NYSE:LLY.N) revealed that it had received a subpoena from the U.S. Department of Justice connected to a manufacturing site in New Jersey that produces bamlanivimab, one of two COVID-19 monoclonal antibodies it produces. The plant also produces the blockbuster Trulicity and cancer drugs. Lilly did not state which types…